AI-generated analysis. Always verify with the original filing.
Ocugen, Inc. filed a Section 205 petition in the Delaware Court of Chancery on February 12, 2026, seeking validation of its Certificate of Amendment increasing authorized common shares from 295,000,000 to 390,000,000, approved at the 2024 Annual Meeting, and all common shares issued in reliance thereon. A hearing is scheduled for May 6, 2026, following grant of motion to expedite.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 12, 2026, Ocugen, Inc. (the “Company”) filed a petition (the “Petition”) in the Court of Chancery of the State of Delaware pursuant to
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Petition filed by Ocugen, Inc. in the Delaware Court of Chancery on February 12, 20